OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ELNR.AT57

Elton International Trading Company SA

Specialty ChemicalsVerified

Elton’s capital structure shows a debt-to-equity ratio of 0.37, below the median for the Specialty Chemicals industry, and a current ratio of 2.16, indicating sufficient short-term liquidity to cover obligations. However, net cash is negative after subtracting total debt, signaling potential liquidity constraints. Profitability metrics show a return on equity of 4.87% and return on assets of 2.91%, both below the industry median for Specialty Chemicals, suggesting underperformance in capital efficiency and asset utilization. Operating income of EUR 6.62 million and net income of EUR 3.40 million reflect modest profitability relative to revenue of EUR 175.09 million. Geographic and segment exposure is concentrated in Southeast Europe, Ukraine, and Turkey, with disclosed operations in agriculture, construction, and industrial chemicals. No segment-specific revenue breakdown is available, but the company’s broad product portfolio suggests diversification across end markets. Growth trajectory is unclear, as revenue in the latest period was EUR 175.09 million, with no prior-year comparison provided. Analyst estimates suggest a recent actual revenue of EUR 64.82 million, potentially indicating a seasonal or reporting period mismatch. Risk factors include medium liquidity risk due to negative net cash and low dilution risk, with no dilutive shares outstanding. No recent equity issuance or ATM programs are disclosed, and no material risk factors are flagged in filings. Recent events include a disclosed revenue of EUR 175.09 million and operating cash flow of EUR 3.25 million, with no material earnings surprises or regulatory actions reported in the latest filings.

30-day price · ELNR.AT(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyElton International Trading Company SA
TickerELNR.AT
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Elton International Trading Company SA distributes chemical raw materials and services across multiple industries, including agriculture, construction, and pharmaceuticals.

Classification. Elton is classified under Specialty Chemicals in the Basic Materials sector with 92% confidence.

Elton’s capital structure shows a debt-to-equity ratio of 0.37, below the median for the Specialty Chemicals industry, and a current ratio of 2.16, indicating sufficient short-term liquidity to cover obligations. However, net cash is negative after subtracting total debt, signaling potential liquidity constraints. Profitability metrics show a return on equity of 4.87% and return on assets of 2.91%, both below the industry median for Specialty Chemicals, suggesting underperformance in capital efficiency and asset utilization. Operating income of EUR 6.62 million and net income of EUR 3.40 million reflect modest profitability relative to revenue of EUR 175.09 million. Geographic and segment exposure is concentrated in Southeast Europe, Ukraine, and Turkey, with disclosed operations in agriculture, construction, and industrial chemicals. No segment-specific revenue breakdown is available, but the company’s broad product portfolio suggests diversification across end markets. Growth trajectory is unclear, as revenue in the latest period was EUR 175.09 million, with no prior-year comparison provided. Analyst estimates suggest a recent actual revenue of EUR 64.82 million, potentially indicating a seasonal or reporting period mismatch. Risk factors include medium liquidity risk due to negative net cash and low dilution risk, with no dilutive shares outstanding. No recent equity issuance or ATM programs are disclosed, and no material risk factors are flagged in filings. Recent events include a disclosed revenue of EUR 175.09 million and operating cash flow of EUR 3.25 million, with no material earnings surprises or regulatory actions reported in the latest filings.
Key takeaways
  • Elton’s debt-to-equity ratio of 0.37 is conservative but its negative net cash position raises liquidity concerns.
  • ROE of 4.87% and ROA of 2.91% lag behind industry medians, indicating weak capital efficiency.
  • Geographic exposure is concentrated in Southeast Europe, Ukraine, and Turkey, with no segment-specific revenue breakdown.
  • Analyst estimates suggest a recent revenue of EUR 64.82 million, potentially indicating a seasonal or reporting period mismatch.
  • Low dilution risk and no recent equity issuance support stability in capital structure.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyEUR
Revenue$175.1M
Gross profit$27.4M
Operating income$6.6M
Net income$3.4M
R&D
SG&A
D&A
SBC
Operating cash flow$3.3M
CapEx-$382.6k
Free cash flow$3.0M
Total assets$116.9M
Total liabilities$47.1M
Total equity$69.8M
Cash & equivalents$7.4M
Long-term debt$26.0M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$69.8M
Net cash-$18.6M
Current ratio2.2
Debt/Equity0.4
ROA2.9%
ROE4.9%
Cash conversion96.0%
CapEx/Revenue-0.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricELNR.ATActivity
Op margin3.8%0.4% medp25 -8.0% · p75 16.0%above median
Net margin1.9%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin15.6%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-0.2%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity37.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual EPS0.07 EUR
Last actual revenue64,818,000 EUR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 03:30 UTC#649c2ede
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 03:32 UTCJob: 986d59bc